Case Study
Pharmaceutical Safety Dossiers for Pre-investigational New Drug, Investigational New Drug, and New Drug Application Submissions to FDA, Washington, DC
By Kristian Fried, Ph.D., Dr. rer. nat., DABT, ERT, Senior Consultant
Published
September 5, 2023
Key Contact
Dr. Kristian Fried holds doctoral degrees in both chemistry and toxicology. He is certified by the American Board of Toxicology... Full bio